|
1
|
Monney L, Sabatos CA, Gaglia JL, Ryu A,
Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel
RA, et al: Th1-specific cell surface protein tim-3 regulates
macrophage activation and severity of an autoimmune disease.
Nature. 415:536–541. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu C, Anderson AC, Schubart A, Xiong H,
Imitola J, Khoury SJ, Zheng XX, Strom TB and Kuchroo VK: The Tim-3
ligand galectin-9 negatively regulates T helper type 1 immunity.
Nat Immunol. 6:1245–1252. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sabatos CA, Chakravarti S, Cha E, Schubart
A, Sánchez-Fueyo A, Zheng XX, Coyle AJ, Strom TB, Freeman GJ and
Kuchroo VK: Interaction of Tim-3 and Tim-3 ligand regulates T
helper type 1 responses and induction of peripheral tolerance. Nat
Immunol. 4:1102–1110. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sakuishi K, Apetoh L, Sullivan JM, Blazar
BR, Kuchroo VK and Anderson AC: Targeting Tim-3 and PD-1 pathways
to reverse T cell exhaustion and restore anti-tumor immunity. J Exp
Med. 207:2187–2194. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jones RB, Ndhlovu LC, Barbour JD, Sheth
PM, Jha AR, Long BR, Wong JC, Satkunarajah M, Schweneker M, Chapman
JM, et al: Tim-3 expression defines a novel population of
dysfunctional T cells with highly elevated frequencies in
progressive HIV-1 infection. J Exp Med. 205:2763–2779. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jin HT, Anderson AC, Tan WG, West EE, Ha
SJ, Araki K, Freeman GJ, Kuchroo VK and Ahmed R: Cooperation of
Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral
infection. Proc Natl Acad Sci USA. 107:14733–14738. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fourcade J, Sun Z, Benallaoua M, Guillaume
P, Luescher IF, Sander C, Kirkwood JM, Kuchroo V and Zarour HM:
Upregulation of Tim-3 and PD-1 expression is associated with tumor
antigen-specific CD8+ T cell dysfunction in melanoma
patients. J Exp Med. 207:2175–2786. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Golden-Mason L, Palmer BE, Kassam N,
Townshend-Bulson L, Livingston S, McMahon BJ, Castelblanco N,
Kuchroo V, Gretch DR and Rosen HR: Negative immune regulator Tim-3
is overexpressed on T cells in hepatitis C virus infection and its
blockade rescues dysfunctional CD4+ and CD8+
T cells. J Virol. 83:9122–9130. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sehrawat S, Reddy PB, Rajasagi N,
Suryawanshi A, Hirashima M and Rouse BT: Galectin-9/TIM-3
interaction regulates virus-specific primary and memory CD8 T cell
response. PLoS Pathog. 6:e10008822010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khademi M, Illés Z, Gielen AW, Marta M,
Takazawa N, Baecher-Allan C, Brundin L, Hannerz J, Martin C, Harris
RA, et al: T Cell Ig- and mucin-domain-containing molecule-3
(TIM-3) and TIM-1 molecules are differentially expressed on human
Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear
cells in multiple sclerosis. J Immunol. 172:7169–7176. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McMahan RH, Golden-Mason L, Nishimura MI,
McMahon BJ, Kemper M, Allen TM, Gretch DR and Rosen HR: Tim-3
expression on PD-1+ HCV-specific human CTLs is
associated with viral persistence, and its blockade restores
hepatocyte-directed in vitro cytotoxicity. J Clin Invest.
120:4546–4557. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chiba S, Baghdadi M, Akiba H, Yoshiyama H,
Kinoshita I, Dosaka-Akita H, Fujioka Y, Ohba Y, Gorman JV, Colgan
JD, et al: Tumor-infiltrating DCs suppress nucleic acid-mediated
innate immune responses through interactions between the receptor
TIM-3 and the alarmin HMGB1. Nat Immunol. 13:832–842. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nagahara K, Arikawa T, Oomizu S, Kontani
K, Nobumoto A, Tateno H, Watanabe K, Niki T, Katoh S, Miyake M, et
al: Galectin-9 increases Tim-3+ dendritic cells and
CD8+ T cells and enhances antitumor immunity via
galectin-9-Tim-3 interactions. J Immunol. 181:7660–7669. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sehrawat S, Suryawanshi A, Hirashima M and
Rouse BT: Role of Tim-3/galectin-9 inhibitory interaction in
viral-induced immunopathology: shifting the balance toward
regulators. J Immunol. 182:3191–3201. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ju Y, Hou N, Meng J, Wang X, Zhang X, Zhao
D, Liu Y, Zhu F, Zhang L, Sun W, et al: T cell immunoglobulin- and
mucin-domain-containing molecule-3 (Tim-3) mediates natural killer
cell suppression in chronic hepatitis B. J Hepatol. 52:322–329.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oikawa T, Kamimura Y, Akiba H, Yagita H,
Okumura K, Takahashi H, Zeniya M, Tajiri H and Azuma M:
Preferential involvement of Tim-3 in the regulation of hepatic
CD8+ T cells in murine acute graft-versus-host disease.
J Immunol. 177:4281–4287. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kozdağ G, Ertaş G, Kiliç T, Acar E, Ağir
A, Sahin T, Cetin M, Bildirici U and Ural D: Elevated level of
high-sensitivity C-reactive protein is important in determining
prognosis in chronic heart failure. Med Sci Monit. 16:CR156–CR161.
2010.PubMed/NCBI
|
|
18
|
Sakhdari A, Mujib S, Vali B, Yue FY,
MacParland S, Clayton K, Jones RB, Liu J, Lee EY, Benko E, et al:
Tim-3 negatively regulates cytotoxicity in exhausted
CD8+ T cells in HIV infection. PLoS One. 7:e401462012.
View Article : Google Scholar : PubMed/NCBI
|
